Partnership will give patients across Egypt unprecedented access to latest pharmaceutical treatments available: Ibnsina Pharma Chairperson
Latest in Tag: Bayer Highlight
Latest in Tag: Bayer
The initiative aims to raise awareness of precautionary measures against the novel coronavirus (Covid-19) and good hygiene habits, especially among underprivileged families.
Another heavy blow has been dealt to German company Bayer. The firm was ordered by a US court to pay compensation in yet another glyphosate-related case. Bayer needs to act swiftly, say DW’s Henrik Böhme.Bayer just needs a pocket calculator to figure out what's coming it's way. Let's assume that each of the remaining 13,400 …
German chemicals and pharmaceuticals giant Bayer has reported lower earnings for its second quarter. The drop came as the firm presented its first financial statement after the mammoth takeover of Monsanto.Bayer announced Wednesday it had logged net profits of €799 million ($926 million) in the second quarter, marking a 34.7 percent drop from bottom-line profits …
Shares in German pharmaceuticals and chemicals giant Bayer have taken a dive to their lowest level in five years. Investors reacted to a shock US ruling against Monsanto, which now belongs to the Leverkusen-based firm.Shares in German chemicals behemoth Bayer tumbled more than 10 percent only half an hour into regular trading on Monday morning. …
German pharma giant Bayer has won approval from the US Justice Department for its planned $62.5 billion takeover of Monsanto. Under the deal, Bayer will be required to carry out largest divestiture in US history.German pharmaceutical giant Bayer cleared a major hurdle in its planned $62.5 billion (€54 billion) takeover of US agrochemical company Monsanto …
German pharmaceutical giant Bayer has reported strong earnings and sales for the third quarter on higher demand for prescription drugs.
Monsanto’s takeover by Bayer could create a GMO juggernaut too powerful for Europe to resist, while conveniently “disappearing” a tarnished brand, critics say. Concerns abound over concentration in the seed market.
Monsanto has rejected a second takeover bid from Bayer, calling it “insufficient”, despite the additional $3 billion (2.7 billion euros) the German drugs and chemicals giant added to its previous offer.
The German pharmaceutical giant has sweetened its buyout deal for Monsanto, which turned down an earlier offer. Bayer has added three dollars more per share, and it has its cash ready if the massive deal is accepted.
US agribusiness giant Monsanto has rejected a multi-billion takeover bid by German pharma and crop science firm Bayer, saying the offer was too low. However, they were open to further talks on a merger, they said.
A merger of the world’s biggest producers of seeds and pesticides may soon be in the making. Missouri-based Monsanto confirmed reports that it received a bid from Germany’s biggest drugs and chemicals firm Bayer.